VIRUS ENCODED MIMITOPE PROCESSING IN AUTOIMMUNE DIABETES
VIRUS ENCODED MIMITOPE PROCESSING IN AUTOIMMUNE DIABETES
批准号:
2673021
负责人:
David V Serreze
金额:
$8.11万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1997
资助国家:
美国
项目状态:
已结题
起止时间:
1997-06-01 至 2000-05-31
中文摘要
描述(改编自申请人摘要):在人类和NOD中
英文摘要
DESCRIPTION (adapted from applicant's abstract): In both humans and the NOD
mouse model, insulin dependent diabetes (IDDM) results from autoimmune
destruction of pancreatic beta cells by T lymphocytes. Thus far, it is not
known which specific subpopulations of antigen presenting cells (APCs - B
lymphocytes, macrophages or dendritic cells) contribute to the development
and activation of diabetogenic T lymphocytes. Preliminary data show that B
lymphocytes play an essential role, since disease incidence is completely
inhibited in a stock of NOD mice made B lymphocyte deficient by congenic
transfer of a functionally disrupted Ig-mu allele (NOD.Ig-mu null).
Preliminary data also show that B lymphocytes are the only APC population
that can immunologically process glutamic acid decarboxylase (GAD), which
may be the earliest beta cell antigen targeted by autoreactive T lymphocytes
in NOD mice. In addition, an epitope in GAD that is reported to be
preferentially presented by APC to autoreactive T lymphocytes in both NOD
mice and human IDDM patients is highly homologous with a segment of the
Coxsackie virus P2-C protein. Thus Coxsackie virus infection may provide a
cross-reactive antigenic trigger for the activation of diabetogenic GAD
autoreactive T lymphocytes in genetically susceptible individuals.
Furthermore, normally quiescent, diabetogenic T lymphocytes may still
develop in B lymphocyte deficient NOD.Ig-mu null mice if other
subpopulations of APC have the capacity to generate mimics of beta cell
autoantigens from infectious agents such as Coxsackie virus. To test this
hypothesis, the investigators will pursue two major aims. The first is to
determine whether B lymphocytes are required for the development as well the
functional activation of T lymphocytes capable of responding to various
GAD-derived peptides in NOD mice. The second is to determine if IDDM
resistance in NOD.Ig-mu null mice can be abrogated by priming with GAD
derived peptides or a Coxsackie viral infection that may bypass the normal
requirement for B lymphocytes to generate antigenic epitopes from native
GAD. These studies will provide insights to the basic mechanisms by which
beta cell antigens are presented to autoreactive T lymphocytes in IDDM, and
how these processes may be influenced by a Coxsackie viral infection.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
B-lymphocyte Targeting Therapies for Autoimmune Diabetes
-
批准号:10440062
-
项目类别:
-
资助金额:$53.17万
-
财政年份:2013
-
负责人:David V Serreze
-
依托单位:
B-lymphocyte Targeting Therapies for Autoimmune Diabetes
-
批准号:9925207
-
项目类别:
-
资助金额:$53.97万
-
财政年份:2013
-
负责人:David V Serreze
-
依托单位:
B-lymphocyte Targeting Therapies for Autoimmune Diabetes
-
批准号:9043052
-
项目类别:
-
资助金额:$38.4万
-
财政年份:2013
-
负责人:David V Serreze
-
依托单位:
B-lymphocyte Targeting Therapies for Autoimmune Diabetes
-
批准号:8641351
-
项目类别:
-
资助金额:$38.4万
-
财政年份:2013
-
负责人:David V Serreze
-
依托单位:
B-lymphocyte Targeting Therapies for Autoimmune Diabetes
-
批准号:8501988
-
项目类别:
-
资助金额:$38.39万
-
财政年份:2013
-
负责人:David V Serreze
-
依托单位:
B-lymphocyte Targeting Therapies for Autoimmune Diabetes
-
批准号:10609074
-
项目类别:
-
资助金额:$54.37万
-
财政年份:2013
-
负责人:David V Serreze
-
依托单位:
Type 1 Diabetes Mouse Resource (T1DR)
-
批准号:8435054
-
项目类别:
-
资助金额:$250.0万
-
财政年份:2012
-
负责人:David V Serreze
-
依托单位:
Becton Dickinson LSR-II Analytical Cytometer (BD-LSR-II)
-
批准号:7388576
-
项目类别:
-
资助金额:$27.52万
-
财政年份:2008
-
负责人:David V Serreze
-
依托单位:
VIRUS ENCODED MIMITOPE PROCESSING IN AUTOIMMUNE DIABETES
-
批准号:2371913
-
项目类别:
-
资助金额:$8.11万
-
财政年份:1997
-
负责人:David V Serreze
-
依托单位:
VIRUS ENCODED MIMITOPE PROCESSING IN AUTOIMMUNE DIABETES
-
批准号:2887472
-
项目类别:
-
资助金额:$8.11万
-
财政年份:1997
-
负责人:David V Serreze
-
依托单位:
ANTIGEN PRESENTING CELL DEFECTS IN AUTOIMMUNE DIABETES
-
批准号:2152202
-
项目类别:
-
资助金额:$18.27万
-
财政年份:1996
-
负责人:David V Serreze
-
依托单位:
ANTIGEN PRESENTING CELL DEFECTS IN AUTOIMMUNE DIABETES
-
批准号:2905849
-
项目类别:
-
资助金额:$20.56万
-
财政年份:1996
-
负责人:David V Serreze
-
依托单位:
Antigen Presenting Cell Defects in Autoimmune Diabetes
-
批准号:7029036
-
项目类别:
-
资助金额:$34.44万
-
财政年份:1996
-
负责人:David V Serreze
-
依托单位:
ANTIGEN PRESENTING CELL DEFECTS IN AUTOIMMUNE DIABETES
-
批准号:6635064
-
项目类别:
-
资助金额:$33.0万
-
财政年份:1996
-
负责人:David V Serreze
-
依托单位:
Antigen Presenting Cell Defects in Autoimmune Diabetes
-
批准号:7336294
-
项目类别:
-
资助金额:$32.77万
-
财政年份:1996
-
负责人:David V Serreze
-
依托单位:
ANTIGEN PRESENTING CELL DEFECTS IN AUTOIMMUNE DIABETES
-
批准号:6757986
-
项目类别:
-
资助金额:$33.0万
-
财政年份:1996
-
负责人:David V Serreze
-
依托单位:
ANTIGEN PRESENTING CELL DEFECTS IN AUTOIMMUNE DIABETES
-
批准号:2713431
-
项目类别:
-
资助金额:$19.77万
-
财政年份:1996
-
负责人:David V Serreze
-
依托单位:
ANTIGEN PRESENTING CELL DEFECTS IN AUTOIMMUNE DIABETES
-
批准号:2430260
-
项目类别:
-
资助金额:$19.01万
-
财政年份:1996
-
负责人:David V Serreze
-
依托单位:
ANTIGEN PRESENTING CELL DEFECTS IN AUTOIMMUNE DIABETES
-
批准号:6517390
-
项目类别:
-
资助金额:$33.0万
-
财政年份:1996
-
负责人:David V Serreze
-
依托单位:
ANTIGEN PRESENTING CELL DEFECTS IN AUTOIMMUNE DIABETES
-
批准号:6192580
-
项目类别:
-
资助金额:$33.0万
-
财政年份:1996
-
负责人:David V Serreze
-
依托单位:
海外基金